Caution urged in use of mesh implants following review of patients
MESH implants should not be recommended as a firstline treatment for certain conditions, according to a new study.
The procedure can be used to treat women suffering from prolapse and bladder problems, but an independent review was ordered in 2014 after women left suffering from painful complications lobbied Holyrood.
A new study published in The Lancet explained current evidence supports the use of mesh implant procedures for incontinence and for prolapse of the top of the vagina.
However, mesh procedures for prolapse involving the bladder or bowel were less effective than non-mesh operations and much more likely to lead to long-term issues.
The study was carried out by the NHS Information Services Division (ISD), which was asked to undertake an independent analysis of the outcomes following mesh and non-mesh operations that were carried out in Scotland.
ISD public health medicine consultant Dr Rachael Wood, who led the study, said: “Some mesh procedures are likely to be relatively safe and effective for some patients.
“Having said that, the results of this study show that mesh procedures should not be recommended as first-line treatment for prolapse of the bladder or bowel.”
She added: “Women considering mesh surgery, or concerned about complications, should speak to their GP or surgeon first .”
In June 2014, the then health secretary Alex Neil asked health boards to suspend the use of the implants after a campaign by women who have suffered serious side effects.
MSPs heard that about 400 mesh implant operations have been carried out since ministers called for them to be suspended.
The figure was quoted by Labour MSP Neil Findlay, who told the Scottish Parliament of the “devastating life-changing consequences” experienced by some women who have had the procedure.
Health Secretary Shona Robison said the Scottish Government has no authority to withdraw the products and confirmed that a review on the issue will be published early in the new year.